Pacira BioSciences, Inc. (PCRX) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pacira Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.298 Good day, and thank you for standing by. Welcome to the first quarter 2025 Spacira 00:00:05.298 -- 00:00:09.965 Biosciences Earnings Conference Call. At this time, all participants are in listen-only 00:00:09.965 -- 00:00:14.291 mode. After the speaker's presentation, there will be the question and answer session. 00:00:14.291 -- 00:00:18.336 To ask a question during the session, you will need to press star 11 on your telephone 00:00:18.336 -- 00:00:22.802 keypad. You will then hear an automatic message advising your hand is raised. 00:00:22.802 -- 00:00:25.226 To withdraw a question, please press star 11 again. 00:00:25.226 -- 00:00:29.157 Please be advised that this conference is being recorded. 00:00:29.157 -- 00:00:33.261 I would now like to hand the conference over to our first speaker today, Susan Meskel, 00:00:33.261 -- 00:00:35.824 Head of Investor Relations. Please go ahead. 00:00:35.824 -- 00:00:37.824 Thank 00:00:38.586 -- 00:00:42.871 you, and good afternoon, everyone. Welcome to today's conference call to discuss our 00:00:42.871 -- 00:00:48.376 first quarter 2025 financial results. Joining me are Frank Lee, Chief Executive 00:00:48.376 -- 00:00:53.642 Officer, Jonathan Slonin, Chief Medical Officer, and Sean Krause, Chief Financial 00:00:53.642 -- 00:00:58.837 Officer. Tony Malloy, Chief Legal and Compliance Officer, and Brandon Tehan, Chief 00:00:58.837 -- 00:01:03.103 Commercial Officer, are also here for today's question and answer session. 00:01:03.103 -- 00:01:07.950 Before we begin, let me remind you that this call will include forward-looking statements 00:01:07.950 -- 00:01:11.716 subject to the safe harbor provisions of federal security laws. 00:01:11.716 -- 00:01:17.905 Such statements represent our judgment...